Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 234

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9C
Chunk 234
---
 Plan automatically will terminate on October 4, 2033, unless it is terminated sooner.

113

Director
Compensation 

Prior
to our 2024 initial public offering, we did not have a formal policy to compensate our non-employee directors. Following our initial
public offering, our non-employee directors are eligible to receive the following cash retainers and equity awards. The retainers will
be payable in four equal installments in each calendar quarter and will be payable within five business days of the end of each calendar
quarter, and with such amount for any partial calendar quarter being appropriately prorated.

    Annual Retainer for Board Membership 

    Annual service on the board of directors 
    $30,000 
  
    Additional Annual Retainer for Committee Membership 

    Annual service as member of the audit committee (other than chair) 
    $5,000 
  
    Annual service as chair of the audit committee 
    $10,000 
  
    Annual service as member of the compensation committee (other than chair) 
    $5,000 
  
    Annual service as chair of the compensation committee 
    $10,000 
  
    Annual service as member of the nominating and corporate governance committee (other than chair) 
    $4,000 
  
    Annual service as chair of the nominating and corporate governance committee 
    $7,500 

Upon
initial election to our board of directors, each non-employee director will be granted an option to acquire up to 18,000 shares of the
common stock at an exercise price of $5.00 per share (subject to customary adjustments), which options shall vest ratably over 36 months,
subject to the director continuing to serve as a director of the Company during such period, pursuant to the Option Award Agreement.
During the term of the independent director agreements, the Company will reimburse each director for all reasonable out-of-pocket expenses
incurred by the director in attending any in-person meetings, provided that the director complies with the generally applicable policies,
practices and procedures of the Company for submission of expense reports, receipts or similar documentation of such expenses. Any reimbursements
for allocated expenses (as compared to out-of-pocket expenses of the director in excess of $500) must be approved in advance by the Company.

Other
than as set forth in the table below and as described more fully below, we did not pay any compensation or make any equity awards or
non-equity awards to any of our